Nm23-H1 regulates contact inhibition of locomotion, which is affected by ephrin-B1

Journal of Cell Science

Volumn 125, Issue 18, 2012, Pages 4343-4353

  Tanaka, Masamitsu ^a   Kuriyama, Sei ^a   Aiba, Namiko ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Contact inhibition; Eph; Ephrin; Glioma; Nm23

Indexed keywords

ALPHA CATENIN; EPHRIN B1; MEMBRANE PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; RAC1 PROTEIN; TIAM1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CONTACT; CELL INVASION; CELL LINE; CELL MIGRATION; CONTACT INHIBITION; CONTACT INHIBITION OF LOCOMOTION; CONTROLLED STUDY; GLIA; GLIOBLASTOMA; GROWTH INHIBITION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPHEROID CELL; TUMOR CELL;

ALPHA CATENIN; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CADHERINS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CONTACT INHIBITION; EPHRIN-B1; GLIOBLASTOMA; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEUROGLIA; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTEIN BINDING; RATS; RATS, WISTAR;

EID: 84872177652     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.104083     Document Type: Article

References (41)

1. Abercrombie, M. and Heaysman, J. E. M. (1953). Observations on the social behaviour of cells in tissue culture. I. Speed of movement of chick heart fibroblasts in relation to their mutual contacts. Exp. Cell Res. 5, 111-131.
2. Aktary, Z., Chapman, K., Lam, L., Lo, A., Ji, C., Graham, K., Cook, L., Li, L., Mackey, J. R. and Pasdar, M. (2010). Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1. Oncogene 29, 2118-2129.
3. Astin, J. W., Batson, J., Kadir, S., Charlet, J., Persad, R. A., Gillatt, D., Oxley, J. D. and Nobes, C. D. (2010). Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat. Cell Biol. 12, 1194-1204.
4. Batlle, E., Bacani, J., Begthel, H., Jonkheer, S., Gregorieff, A., van de Born, M., Malats, N., Sancho, E., Boon, E., Pawson, T. et al. (2005). EphB receptor activity suppresses colorectal cancer progression. Nature 435, 1126-1130.
5. Boissan, M., Wendum, D., Arnaud-Dabernat, S., Munier, A., Debray, M., Lascu, I., Daniel, J. Y. and Lacombe, M. L. (2005). Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J. Natl. Cancer Inst. 97, 836-845.
6. Boissan, M., Dabernat, S., Peuchant, E., Schlattner, U., Lascu, I. and Lacombe, M. L. (2009). The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Mol. Cell. Biochem. 329, 51-62.
7. Boissan, M., De Wever, O., Lizarraga, F., Wendum, D., Poincloux, R., Chignard, N., Desbois-Mouthon, C., Dufour, S., Nawrocki-Raby, B., Birembaut, P. et al. (2010). Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res. 70, 7710-7722.
8. Carmona-Fontaine, C., Matthews, H. K., Kuriyama, S., Moreno, M., Dunn, G. A., Parsons, M., Stern, C. D. and Mayor, R. (2008). Contact inhibition of locomotion in vivo controls neural crest directional migration. Nature 456, 957-961.
9. Castaño, J., Davalos, V., Schwartz, S., Jr and Arango, D. (2008). EPH receptors in cancer. Histol. Histopathol. 23, 1011-1023.
10. Castellvi, J., Garcia, A., de la Torre, J., Hernandez, J., Gil, A., Xercavins, J. and Ramón y Cajal, S. (2006). Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis. Hum. Pathol. 37, 883-889.
11. Daar, I. (2012). Non-SH2/PDZ reverse signaling by ephrins. Semin. Cell Dev. Biol. 23, 65-74.
12. Fan, Z., Beresford, P. J., Oh, D. Y., Zhang, D. and Lieberman, J. (2003). Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112, 659-672.
13. Golembieski, W. A., Ge, S., Nelson, K., Mikkelsen, T. and Rempel, S. A. (1999). Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int. J. Dev. Neurosci. 17, 463-472.
14. Habets, G. G., Scholtes, E. H., Zuydgeest, D., van der Kammen, R. A., Stam, J. C., Berns, A. and Collard, J. G. (1994). Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77, 537-549.
15. Hartsough, M. T., Morrison, D. K., Salerno, M., Palmieri, D., Ouatas, T., Mair, M., Patrick, J. and Steeg, P. S. (2002). Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J. Biol. Chem. 277, 32389-32399.
16. Holmberg, J., Genander, M., Halford, M. M., Annerén, C., Sondell, M., Chumley, M. J., Silvany, R. E., Henkemeyer, M. and Frisén, J. (2006). EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 125, 1151-1163.
17. Iwashita, S., Fujii, M., Mukai, H., Ono, Y. and Miyamoto, M. (2004). Lbc protooncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2. Biochem. Biophys. Res. Commun. 320, 1063-1068.
18. Jung, S., Paek, Y. W., Moon, K. S., Wee, S. C., Ryu, H. H., Jeong, Y. I., Sun, H. S., Jin, Y. H., Kim, K. K. and Ahn, K. Y. (2006). Expression of Nm23 in gliomas and its effect on migration and invasion in vitro. Anticancer Res. 26, 249-258.
19. Kataoka, H., Tanaka, M., Kanamori, M., Yoshii, S., Ihara, M., Wang, Y. J., Song, J. P., Li, Z. Y., Arai, H., Otsuki, Y. et al. (2002). Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. J. Cancer Res. Clin. Oncol. 128, 343-348.
20. Lacombe, M. L., Milon, L., Munier, A., Mehus, J. G. and Lambeth, D. O. (2000). The human Nm23/nucleoside diphosphate kinases. J. Bioenerg. Biomembr. 32, 247-258.
21. Mayor, R. and Carmona-Fontaine, C. (2010). Keeping in touch with contact inhibition of locomotion. Trends Cell Biol. 20, 319-328.
22. McDermott, W. G., Boissan, M., Lacombe, M. L., Steeg, P. S. and Horak, C. E. (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin. Exp. Metastasis 25, 131-138.
23. Meyer, S., Hafner, C., Guba, M., Flegel, S., Geissler, E. K., Becker, B., Koehl, G. E., Orsó, E., Landthaler, M. and Vogt, T. (2005). Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. Int. J. Oncol. 27, 1197-1206.
24. Nakada, M., Anderson, E. M., Demuth, T., Nakada, S., Reavie, L. B., Drake, K. L., Hoelzinger, D. B. and Berens, M. E. (2010). The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. Int. J. Cancer 126, 1155-1165.
25. Otsuki, Y., Tanaka, M., Yoshii, S., Kawazoe, N., Nakaya, K. and Sugimura, H. (2001). Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc. Natl. Acad. Sci. USA 98, 4385-4390.
26. Pasquale, E. B. (2008). Eph-ephrin bidirectional signaling in physiology and disease. Cell 133, 38-52.
27. Poliakov, A., Cotrina, M. and Wilkinson, D. G. (2004). Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev. Cell 7, 465-480.
28. Rosenzweig, T., Ziv-Av, A., Xiang, C., Lu, W., Cazacu, S., Taler, D., Miller, C. G., Reich, R., Shoshan, Y., Anikster, Y. et al. (2006). Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Cancer Res. 66, 4139-4148.
29. Steeg, P. S., Ouatas, T., Halverson, D., Palmieri, D. and Salerno, M. (2003). Metastasis suppressor genes: basic biology and potential clinical use. Clin. Breast Cancer 4, 51-62.
30. Suzuki, E., Ota, T., Tsukuda, K., Okita, A., Matsuoka, K., Murakami, M., Doihara, H. and Shimizu, N. (2004). nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int. J. Cancer 108, 207-211.
31. Tanaka, M., Ohashi, R., Nakamura, R., Shinmura, K., Kamo, T., Sakai, R. and Sugimura, H. (2004). Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2. EMBO J. 23, 1075-1088.
32. Tanaka, M., Kamata, R. and Sakai, R. (2005). Phosphorylation of ephrin-B1 via the interaction with claudin following cell-cell contact formation. EMBO J. 24, 3700-3711.
33. Tanaka, M., Sasaki, K., Kamata, R. and Sakai, R. (2007a). The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells. J. Cell Sci. 120, 2179-2189.
34. Tanaka, M., Kamata, R., Takigahira, M., Yanagihara, K. and Sakai, R. (2007b). Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma. Am. J. Pathol. 171, 68-78.
35. Tanaka, M., Kamata, R., Yanagihara, K. and Sakai, R. (2010). Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Sci. 101, 87-93.
36. Terawaki, S., Kitano, K., Mori, T., Zhai, Y., Higuchi, Y., Itoh, N., Watanabe, T., Kaibuchi, K. and Hakoshima, T. (2010). The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module. EMBO J. 29, 236-250.
37. Theveneau, E., Marchant, L., Kuriyama, S., Gull, M., Moepps, B., Parsons, M. and Mayor, R. (2010). Collective chemotaxis requires contact-dependent cell polarity. Dev. Cell 19, 39-53.
38. Varelias, A., Koblar, S. A., Cowled, P. A., Carter, C. D. and Clayer, M. (2002). Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. Cancer 95, 862-869.
39. Vaught, D., Brantley-Sieders, D. M. and Chen, J. (2008). Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. Breast Cancer Res. 10, 217-224.
40. Wagner, P. D., Steeg, P. S. and Vu, N. D. (1997). Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc. Natl. Acad. Sci. USA 94, 9000-9005.
41. Zhang, Q., McCorkle, J. R., Novak, M., Yang, M. and Kaetzel, D. M. (2011). Metastasis suppressor function of NM23-H1 requires its 39 to 59 exonuclease activity. Int. J. Cancer 128, 40-50.